We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Supreme Court Shouldn't Hear Tamoxifen Cases: SG

Law360 (May 23, 2007, 12:00 AM EDT) -- The U.S. Supreme Court should not use the Tamoxifen Citrate antitrust lawsuits as an opportunity to weigh in on the issue of authorized generics, even though the appeals court that decided...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.